REVIMEX
ActiveREVIMEX has been active since 1991 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.00M and a net result of €372k. Equity is growing by ~4.3% per year across the filed fiscal years. Its solvency ranks better than 49% of 4860 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2025
69
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability78▼-4
Solvency70▼-5
Growth63▲+4
Track record100
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €65k at 30 days acceptable
Liquidity ample (current ratio 1.67 against 1.78 in 2024; short-term debt: 54.6% and cash: 5.5% of total assets), but 55.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
44.9%
Return on assets
16.7%
Age of the figures
9 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies
more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 25-03-2026, 128 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
128 d early
2024
37 d early
2023
2 d early
2022
88 d early
2021
82 d early
2020
65 d early
2019
67 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
21-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, full schema
Turnover
€7.05M▲ 4.3%
2024 · €6.76M
2023: €6.99M
2024: €6.76M
2023 → 2025
EBIT margin
7.3%▼ 1.2pp
2024 · 8.5%
2023: 7.3%
2024: 8.5%
2023 → 2025
Net result
€372k▼ 8.2%
2024 · €406k
2018: €178k
2019: €148k
2020: €143k
2021: €229k
2022: €198k
2023: €370k
2024: €406k
2018 → 2025
Working capital
€816k▲ 5.2%
2024 · €776k
2018: €606k
2019: €700k
2020: €797k
2021: €938k
2022: €901k
2023: €822k
2024: €776k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Turnover€6.99M€6.76M▼ 3.2%€7.05M▲ 4.3%
Equity€1.00M-€1.00M=€1.00M=€1.00M=€1.00M=
Operating result€318k-€288k▼ 9.4%€512k▲ 77.7%€574k▲ 12.1%€515k▼ 10.3%
Net result€229k-€198k▼ 13.7%€370k▲ 87.3%€406k▲ 9.5%€372k▼ 8.2%
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 10% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.23M
Fixed assets
€195k▼ 20.4%
Current assets
€2.03M▲ 15.1%
Equity and liabilities €2.23M
Equity
€1.00M=
Debt
€1.23M▲ 21.4%
The debt ratio rises from 50.3% to 55.1%. Debt is higher.
Key figures and ratios
EBITDA
€597k▼
2024 · €639k
Cash flow
€455k▼
2024 · €471k
Solvency
44.9%▼
2024 · 49.7%
Current ratio
1.67▼
2024 · 1.78
Quick ratio
1.05▲
2024 · 1.02
Debt / equity
1.23▲
2024 · 1.01
ROE
37.2%▼
2024 · 40.6%
ROA
16.7%▼
2024 · 20.2%
Interest coverage
357.31▲
2024 · 289.41
Debt
€1.23M▲
2024 · €1.01M
Debt ≤ 1 year
€1.22M▲
2024 · €989k
Debt > 1 year
€8k▼
2024 · €21k
Income taxes
€132k▼
2024 · €148k
Staff costs
€386k▲
2024 · €363k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€2.01M€2.23M▲
Fixed assets21/28€246k€195k▼
Tangible fixed assets22/27€246k€195k▼
Plant, machinery and equipment23€51k€29k▼
Furniture and vehicles24€164k€140k▼
Other tangible fixed assets26€30k€27k▼
Financial fixed assets28€6€6=
Other financial fixed assets284/8€6€6=
Amounts receivable and cash guarantees285/8€6€6=
Current assets29/58€1.77M€2.03M▲
Stocks and contracts in progress3€754k€760k▲
Stocks30/36€754k€760k▲
Goods purchased for resale34€754k€760k▲
Amounts receivable within one year40/41€526k€1.12M▲
Trade receivables40€526k€1.12M▲
Other amounts receivable41€0-
Cash at bank and in hand54/58€477k€122k▼
Deferred charges and accrued income490/1€8k€27k▲
Equity and liabilities
Total equity and liabilities10/49€2.01M€2.23M▲
Equity10/15€1.00M€1.00M=
Contributions10/11€19k€19k=
Reserves13€981k€981k=
Non-distributable reserves130/1€2k€0▼
Reserves not available under the articles1311€2k€0▼
Distributable reserves133€980k€981k▲
Amounts payable17/49€1.01M€1.23M▲
Amounts payable after more than one year17€21k€8k▼
Financial debts170/4€21k€8k▼
Credit institutions173€21k€8k▼
Amounts payable within one year42/48€989k€1.22M▲
Current portion of amounts payable after more than one year42€12k€13k▲
Trade debts44€457k€706k▲
Suppliers440/4€457k€706k▲
Taxes, remuneration and social security45€114k€124k▲
Taxes450/3€69k€81k▲
Remuneration and social security454/9€45k€43k▼
Other amounts payable47/48€406k€372k▼
Accrued charges and deferred income492/3€500€3k▲
Income statement
Code20242025
Operating income70/76A€6.79M€7.10M▲
Turnover70€6.76M€7.05M▲
Other operating income74€30k€28k▼
Non-recurring operating income76A€0€16k▲
Operating charges60/66A€6.22M€6.58M▲
Goods for resale, raw materials and consumables60€5.16M€5.42M▲
Purchases600/8€5.12M€5.42M▲
Change in stocks: decrease (increase)609€38k€-6k▼
Services and other goods61€608k€675k▲
Remuneration, social security and pensions62€363k€386k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€65k€82k▲
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€0€2k▲
Other operating charges640/8€21k€17k▼
Operating profit (loss)9901€574k€515k▼
Financial income75/76B€1k€15k▲
Recurring financial income75€1k€11k▲
Income from current assets751€15€29▲
Other financial income752/9€1k€11k▲
Non-recurring financial income76B-€4k
Financial charges65/66B€21k€26k▲
Recurring financial charges65€21k€26k▲
Debt charges650€2k€2k▼
Other financial charges652/9€19k€24k▲
Profit (loss) for the period before taxes9903€554k€504k▼
Income taxes67/77€148k€132k▼
Taxes670/3€148k€132k▼
Profit (loss) for the period9904€406k€372k▼
Profit (loss) for the period to be appropriated9905€406k€372k▼
Appropriation of the result
Profit (loss) to be appropriated9906€406k€372k▼
Profit to be distributed694/7€406k€372k▼
Return on contributions (dividend)694€406k€372k▼
Social balance
Average headcount (FTE)90876.36.1▼
The notes to these accounts (68 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
25-03
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
24-06
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial
Highest result since 2018net €406k ▲9.5%
Operating result €574k, net result €406k, both a record.
29-07
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
04-05
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
10-05
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
31-12
Financial
Equity above €1MEq €1.00M ▲15.8%
4 profitable years in a row build equity to €1.00M.
27-05
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
31-12
Financial
Weakest financial yearnet €143k ▼3.6%
Net result drops to €143k, the lowest in the series; recovery starts the following year.
25-05
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
27-05
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
05-07
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
16-05
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Pelt · 1 establishment unit since 1991
Ground area
1.8 ha
Building footprint
3,825 m²
Volume, LiDAR
25,224 m³
Parcel 72502E0102/00D153, Flanders · tallest building 7.5 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
REVIMEX
since 19912.052.030.941
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 72502E0102/00D153 | Flanders | 1.8 ha | 2 · 3,825 m² | 7.5 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2023 · 1 entry · 257 EUR awarded · 257 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2023 | 1 | 257 EUR | 257 EUR |
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Similar companies · same sector, comparable size
ORTHO SINA
BE 0889.872.555
Jette · Eq €999k
DIMED MEDICAL ENGINEERING
BE 0451.042.674
Antwerpen · Eq €1.00M
SEPTODONT NV-SA
BE 0415.827.815
Ganshoren · Eq €996k
AIP Medical
BE 0450.686.744
Olne · Eq €1.01M
BIOTECHNOLOGICAL ENZYMATIC CATALYSE
BE 0446.755.472
Merelbeke-Melle · Eq €1.01M
Of 1,898 companies in sector 46460 we hold annual accounts for 1,116. 758 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded01-03-1991
Fiscal year end31-12
Activities, NACEBEL
30920Manufacture of other transport equipment
33103
35430
46460Wholesale of pharmaceutical and medical goods
32500Manufacture of medical and dental instruments and supplies
47740Retail trade
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
52320
77225Rental and leasing activities
Sources
Crossroads Bank for EnterprisesNational Bank · 35 filingsAddress and cadastre registers
Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.